JRCT ID: jRCTs051210205
Registered date:25/03/2022
Development of a diagnostic method for pancreatic cancer using 13C glucose
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | Pancreatic cancer, benign pancreatic diseases, or other gastroenterological cancers |
Date of first enrollment | 30/05/2023 |
Target sample size | 60 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | Oral administration of 13C-labeled glucose |
Outcome(s)
Primary Outcome | Level of 13C glucose-derived metabolites present in urine after 13C glucose administration |
---|---|
Secondary Outcome | 1. Presence of 13C glucose-derived metabolites in urine after administration of 13C glucose 2. 13C glucose-derived metabolites (unknown metabolites) 3. Metabolites containing 13C 4. Occurrence of disease or symptom |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | <= 80age old |
Gender | Both |
Include criteria | 1. Age over 20, under 80 2. Diagnosed patients of pancreatic cancer, benigh pancreatic disease or other gastroenterological cancer 3. Patients who have given their free and written consent to participate in this clinical research. |
Exclude criteria | 1. ECOG-PS 4, or patients who have difficulty urinating or collecting urine on their own 2. Patients deemed inappropriate by the attending doctor |
Related Information
Primary Sponsor | Tobimatsu Kazutoshi |
---|---|
Secondary Sponsor | Yoshida Masaru |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Takashi Kobayashi |
Address | 7-5-2 Kusunoki-cho,Chuo-ku,Kobe,Hyogo Hyogo Japan 650-0017 |
Telephone | +81-78-382-6305 |
kobatak@med.kobe-u.ac.jp | |
Affiliation | Kobe University Hospital |
Scientific contact | |
Name | Kazutoshi Tobimatsu |
Address | 7-5-2 Kusunoki-cho,Chuo-ku,Kobe,Hyogo Hyogo Japan 650-0017 |
Telephone | +81-78-382-6305 |
tobi@med.kobe-u.ac.jp | |
Affiliation | Kobe University Hospital |